Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin-induced TFPI release in lacunar stroke patients
NL-OMON31866Not yet recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of heparin in lacunar infarct and Cerebral Small Vessel Disease (CSVD) (3 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Objective 1 and Objective 2. Planned start Oct 2008; status: not yet recruiting.
02
Drugs
heparin
03
Conditions
lacunar infarctCerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NL-OMON31866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31866.